How to advance AAV-based gene therapies
Drug Discovery World
OCTOBER 18, 2023
The greater data translatability gives developers the confidence to progress the most promising treatments and reduces clinical failures, thereby slashing project costs and timelines. What’s more, rodents are used widely across preclinical R&D, so most drug development labs already have the infrastructure to utilise them.
Let's personalize your content